BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15611422)

  • 1. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.
    Ruzicka T; Larsen FG; Galewicz D; Horváth A; Coenraads PJ; Thestrup-Pedersen K; Ortonne JP; Zouboulis CC; Harsch M; Brown TC; Zultak M
    Arch Dermatol; 2004 Dec; 140(12):1453-9. PubMed ID: 15611422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
    Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
    Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
    Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of chronic hand dermatitis with 36 continuous months of alitretinoin administration: report of three cases.
    Gulliver WP; Baker KA
    J Cutan Med Surg; 2012; 16(4):267-71. PubMed ID: 22784520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
    Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
    Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alitretinoin in chronic hand eczema: summary of clinical trials].
    Richard MA
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S111-23. PubMed ID: 21185982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study.
    Kunz M; Urosevic-Maiwald M; Goldinger SM; Frauchiger AL; Dreier J; Belloni B; Mangana J; Jenni D; Dippel M; Cozzio A; Guenova E; Kamarachev J; French LE; Dummer R
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):293-8. PubMed ID: 26507685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
    Reich K; Graff O; Mehta N
    Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
    Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
    Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world experience with alitretinoin in a community dermatology practice setting in patients with chronic hand dermatitis.
    Ham K; Maini P; Gooderham MJ
    J Cutan Med Surg; 2014 Oct; 18(5):332-6. PubMed ID: 25186994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
    Gola M; Milanesi N; D'Erme AM
    G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
    Gola M; D'Erme AM; Milanesi N; Marmugi L
    Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alitretinoin: A Review in Severe Chronic Hand Eczema.
    Blair HA; Scott LJ
    Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alitretinoin: a comprehensive review.
    Cheng C; Michaels J; Scheinfeld N
    Expert Opin Investig Drugs; 2008 Mar; 17(3):437-43. PubMed ID: 18321241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral alitretinoin in chronic refractory hand eczema: a "real life" case-series of 12 patients.
    Kubica E; Ezzedine K; Lalanne N; Dartial Y; Taieb A; Milpied B
    Eur J Dermatol; 2011; 21(3):454-6. PubMed ID: 21680291
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
    Aboulafia DM; Norris D; Henry D; Grossman RJ; Thommes J; Bundow D; Yocum RC; Stevens V
    Arch Dermatol; 2003 Feb; 139(2):178-86. PubMed ID: 12588223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.